オーラルセッション
- 第3日 5月21日（金） 14:45～15:25 A会場（Zoom）
-
3A-O11-1445 PDF
質量分析で捉える新規臨床バイオマーカー：ライソゾーム病領域における最近の話題
Clinical biomarker has been attracted much attention due to its beneficial role in diagnosis and drug development. Mass spectrometric assay has greatly contributed for the discovery of novel biomarkers together with other technique such as chromatography, spectroscopy, and organic synthesis. This is also true for the diagnosis of lysosomal storage disorder, a group of congenic disorders with nearly 50 genes in human. Here, we would like to provide several topics on this clinical area with our experience.